You Want Freud with That?  The Added Value of Combining Psychotherapy with Medication for Depression

Boadie Dunlop, M.D., M.S.

Introduction
Dr. Boadie Dunlop is an Associate Professor of Psychiatry and has served as Director of the Emory University Mood and Anxiety Disorders Program for 11 years. He also directs the mood and anxiety disorders didactic module for Emory Psychiatry residents and supervises the resident psychopharmacology clinic at Emory. Dr. Dunlop served as the principal or co-investigator on over 60 NIH- and industry-sponsored clinical trials of medication, psychotherapy, or complementary medicine treatments for mood and anxiety disorders. He is particularly interested in identifying biological and clinical predictors of response to differing treatment approaches for anxiety and mood disorders, and in extending this knowledge into the broader clinical community.  He is currently collaborating with Mayo investigators Mark Frye, MD and Dick Weinshilboum, MD, on an NIH grant investigating the metabolomic and genetic predictors of outcomes to treatment with escitalopram, duloxetine and cognitive behavioral therapy in adults with depression.

Learning Objectives

1. Recognize the impact on outcomes of combination treatment with psychotherapy and medication versus either component alone among adults with major depressive disorder.
2. Identify the limitations of the published literature on combination treatments that may limit generalizability to routine clinical practice.

 
Live webcast available at:  http://videos.mayo.edu/live
1 AMA PRA Category 1 Credit(s)™ hour is offered for watching this Webcast live.  Ethos will be implemented for all post presentation surveys.  To document your attendance, please text the code given at the presentation to 507-200-3010.  For questions, email rstpsychgr@mayo.edu.

Credit Statements
• Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
• Mayo Clinic College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• The Department of Psychiatry and Psychology at Mayo Clinic, Rochester, is approved by the American Psychological Association to sponsor continuing education credits for psychologists. The Department of Psychiatry and Psychology at Mayo Clinic, Rochester maintains responsibility for this program and its content.
• Archived webcast available at: Psychiatry & Psychology Video Library
Industry Acknowledgment (if applicable): None.

NEW in 2017 !!!

All participants MUST complete the evaluation in order to get CME or APA Credit. 

1) Text the CODE announced at the session within 48 hours to (507) 200-3010
2) Login at ce.mayo.edu and go to My Account, My Activities, Pending activities, click Session title and Take Course to access the required Evaluation.
-or-
Click the START button on that session page.
3) Evaluation must be completed within 2 weeks.
 
Disclosure Summary
As a provider accredited by ACCME, Mayo Clinic College of Medicine (Mayo School of Continuous Professional Development), must ensure balance, independence, objectivity and scientific rigor in its educational activities.   Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with industry: 
Boadie Dunlop, M.D., M.S.:  Grant/Research Support:  Acadia, Assurex, Axsome, Janssen, NIMH, Takeda

No relevant financial relationship(s) with industry:
Brian Palmer, M.D., Michael Bostwick, M.D., Karen Grothe, Ph.D., Lois Krahn, M.D., Jarrod Leffler, Ph.D., Larissa Loukianova, M.D., Mary Machulda, Ph.D., Patricia Maus, M.D., Jeffrey Staab, M.D., Cosima Swintak, M.D., Kristin Vickers Douglas, Ph.D., Cynthia Harbeck-Weber, Ph.D., Michael Zaccariello, Ph.D., Charlene Nelson

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None